FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890969745> ?p ?o ?g. }

• W2890969745 endingPage "2072" @default.
• W2890969745 startingPage "2071" @default.
• W2890969745 abstract "Substitution of prescription opioid use by medical cannabis is not public health relevant, as it is restricted to substitution of a small subset of less potent opioids such as codeine. In addition, it substitutes one substance with abuse potential by another, and there are better alternatives available. Liang and colleagues 1 have presented a time–series analysis based on 21 years of state-level data of Medicaid records, in which they found that medical cannabis legalization was associated with substantial reductions in the number of Schedule III opioid prescriptions in the United States (−30%), their dosage (30%) and related Medicaid spending (−29%). Prescription opioids in Schedule III are characterized by lower abuse potential compared to opioids in Schedule II, with abuse of these opioids potentially leading to moderate or low physical dependence and/or high psychological dependence 2. In the analyses of Liang and colleagues 1, the Schedule III prescriptions made up only approximately 5% of all opioid prescriptions for the last year of analysis (2014), with codeine prescriptions comprising 99% of all Schedule III prescriptions. Codeine is used in the United States to treat mild to moderate pain and as a cough suppressant. Cannabis has been in use for both of these indications, and thus a substitution effect may be plausible. What would be the public health implications of a partial substitution? First, the overall substitution was not found to be affecting a large portion of the overall opioid prescription use. Secondly, however, codeine has an abuse potential. Although this abuse potential was evaluated to be lower compared to Schedule II opioids, abuse has been documented with both prescribed and over-the-counter codeine 3. Furthermore, codeine use may contribute as a gateway to other opioids, both prescription and illicit opioids, with high overdose potential 4, 5. Overall, the United States has, by far, globally the highest prescription opioid use per capita 6, and probably also the highest overall opioid use per capita in the world (i.e. combining prescription and illicit use), at least if indirectly inferred by opioid use disorders 7. The overall culture of medically overusing opioids has contributed markedly to this situation 8. What about cannabis? Its scheduling currently seems to be in flux, with many US states starting medical marijuana programs 9. However, while its consequences are not as detrimental as those of other drugs, in particular in terms of mortality 10, they are far from benign 11. Finally, the effectiveness of both codeine and cannabis for relieving moderate chronic pain seems to be limited, with no Cochrane Reviews supporting such a claim as primary drug of choice (e.g. 12, 13). Perhaps this judgement about effectiveness is premature for cannabis, with research to collect better evidence only now commencing, but it reflects the current evidence base. However, from a public health point of view, given the abuse potentials of both drugs involved, perhaps solutions should be sought with non-pharmacological therapies or with medications with less abuse potential than opioids or cannabis. The history of opioids in pain medication in North America should be a lesson. Despite limited evidence for effectiveness, prescription opioids were seen as a wonder drug, especially for pain management, with rapidly accelerating use to the point where they contributed markedly to a high level of opioid addiction on the population level and a major public health crisis 14, and decreasing life expectancies 15, 16. As a result, new national guidelines for opioid pain prescription stress non-pharmacological therapies and non-opioid medication as first-line treatment 17. We should not repeat this history with yet another wonder drug installed before proper evidence for effectiveness and well-documented unintentional consequences. Given the current evidence, there is no good reason not to start pain management with non-pharmacological therapies, but there are good reasons to limit the use of drugs with high abuse potential to the highest degree possible. None. The author acknowledges funding from the Canadian Institutes of Health Research, Institute of Neurosciences, Mental Health and Addiction (CRISM Ontario Node grant no. SMN-13950)." @default.
• W2890969745 created "2018-09-27" @default.
• W2890969745 creator A5080697414 @default.
• W2890969745 date "2018-09-03" @default.
• W2890969745 modified "2023-09-26" @default.
• W2890969745 title "Commentary on Liang <i>et al</i> . (2018): The potential impact of medical cannabis on public health with respect to reducing prescription opioid use and associated harm" @default.
• W2890969745 cites W1974337338 @default.
• W2890969745 cites W2137006494 @default.
• W2890969745 cites W2151383246 @default.
• W2890969745 cites W2154243862 @default.
• W2890969745 cites W2175682905 @default.
• W2890969745 cites W2179042861 @default.
• W2890969745 cites W2556785740 @default.
• W2890969745 cites W2617460484 @default.
• W2890969745 cites W2763922368 @default.
• W2890969745 cites W2784247910 @default.
• W2890969745 cites W2795441436 @default.
• W2890969745 cites W2822255203 @default.
• W2890969745 doi "https://doi.org/10.1111/add.14408" @default.
• W2890969745 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30178539" @default.
• W2890969745 hasPublicationYear "2018" @default.
• W2890969745 type Work @default.
• W2890969745 sameAs 2890969745 @default.
• W2890969745 citedByCount "1" @default.
• W2890969745 countsByYear W28909697452021 @default.
• W2890969745 crossrefType "journal-article" @default.
• W2890969745 hasAuthorship W2890969745A5080697414 @default.
• W2890969745 hasBestOaLocation W28909697451 @default.
• W2890969745 hasConcept C118552586 @default.
• W2890969745 hasConcept C126322002 @default.
• W2890969745 hasConcept C138816342 @default.
• W2890969745 hasConcept C159110408 @default.
• W2890969745 hasConcept C160735492 @default.
• W2890969745 hasConcept C162324750 @default.
• W2890969745 hasConcept C170493617 @default.
• W2890969745 hasConcept C2426938 @default.
• W2890969745 hasConcept C2776534028 @default.
• W2890969745 hasConcept C2777056318 @default.
• W2890969745 hasConcept C2777389121 @default.
• W2890969745 hasConcept C2777866328 @default.
• W2890969745 hasConcept C2779418921 @default.
• W2890969745 hasConcept C2781063702 @default.
• W2890969745 hasConcept C2911204551 @default.
• W2890969745 hasConcept C50522688 @default.
• W2890969745 hasConcept C71924100 @default.
• W2890969745 hasConcept C98274493 @default.
• W2890969745 hasConceptScore W2890969745C118552586 @default.
• W2890969745 hasConceptScore W2890969745C126322002 @default.
• W2890969745 hasConceptScore W2890969745C138816342 @default.
• W2890969745 hasConceptScore W2890969745C159110408 @default.
• W2890969745 hasConceptScore W2890969745C160735492 @default.
• W2890969745 hasConceptScore W2890969745C162324750 @default.
• W2890969745 hasConceptScore W2890969745C170493617 @default.
• W2890969745 hasConceptScore W2890969745C2426938 @default.
• W2890969745 hasConceptScore W2890969745C2776534028 @default.
• W2890969745 hasConceptScore W2890969745C2777056318 @default.
• W2890969745 hasConceptScore W2890969745C2777389121 @default.
• W2890969745 hasConceptScore W2890969745C2777866328 @default.
• W2890969745 hasConceptScore W2890969745C2779418921 @default.
• W2890969745 hasConceptScore W2890969745C2781063702 @default.
• W2890969745 hasConceptScore W2890969745C2911204551 @default.
• W2890969745 hasConceptScore W2890969745C50522688 @default.
• W2890969745 hasConceptScore W2890969745C71924100 @default.
• W2890969745 hasConceptScore W2890969745C98274493 @default.
• W2890969745 hasFunder F4320334506 @default.
• W2890969745 hasFunder F4320338069 @default.
• W2890969745 hasIssue "11" @default.
• W2890969745 hasLocation W28909697451 @default.
• W2890969745 hasLocation W28909697452 @default.
• W2890969745 hasOpenAccess W2890969745 @default.
• W2890969745 hasPrimaryLocation W28909697451 @default.
• W2890969745 hasRelatedWork W1973795974 @default.
• W2890969745 hasRelatedWork W2132829374 @default.
• W2890969745 hasRelatedWork W2198615677 @default.
• W2890969745 hasRelatedWork W2915653773 @default.
• W2890969745 hasRelatedWork W2994037982 @default.
• W2890969745 hasRelatedWork W3119929942 @default.
• W2890969745 hasRelatedWork W3199386864 @default.
• W2890969745 hasRelatedWork W4200144781 @default.
• W2890969745 hasRelatedWork W4251598061 @default.
• W2890969745 hasRelatedWork W4293799040 @default.
• W2890969745 hasVolume "113" @default.
• W2890969745 isParatext "false" @default.
• W2890969745 isRetracted "false" @default.
• W2890969745 magId "2890969745" @default.
• W2890969745 workType "article" @default.